/
Neurology
Traumatic Brain Injury
15
Pipeline Programs↗
103
Active Trials↗
19
Companies Involved↗
Traumatic Brain Injury is an emerging landscape with 15 programs across 19 companies. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
Preclinical6
Phase 15
Choriogonadotropin Alfa
Organon and Co
Allorx
The Foundation for Orthopaedics and Regenerative Medicine
Hyperpolarized [1-13c] Pyruvate
University of Texas Southwestern Medical Center
Hyperpolarized [2-13c] Pyruvate
University of Texas Southwestern Medical Center
Hyperpolarized Pyruvate
Sunnybrook Health Sciences Centre
Approved
No programs
Analysis
Modality Breakdown
92%
Small molecule
11 of 12 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 12 classified programs, each share of the total. Modality classified for 80% of 15 pipeline programs.
Analysis
Trial Status
126
clinical trials
Recruiting52 · 41%
Not yet recruiting30 · 24%
Completed19 · 15%
Active, not recruiting13 · 10%
Enrolling by invitation8 · 6%
Terminated3 · 2%
Other1 · 1%
Clinical Trials
Trial Activity
126 trials
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
Recruiting·—·N/A·NCT03321370·10 enrolled
Mechanisms Underlying Carbon Dioxide Induced Protein Efflux in Health and Traumatic Brain Injury
Recruiting·—·Preclinical·NCT07357090·200 enrolled
Page 1 of 9
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)